Table 6 Frequency of comorbidities and clinical events before and after transplantation in treatment groups
From: The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
|  |  | CsA Group (n = 60) | Tac Group (n = 68) | p value |
|---|---|---|---|---|
Clinical events n (%) | ||||
 Hypertension | Pre-op | 45 (75.0) | 42 (61.8) | 0.109 |
Post-op | 3 (5.0) | 8 (11.8) | 0.216 | |
 Dyslipidemia | Pre-op | 7 (11.7) | 10 (14.7) | 0.795 |
Post-op | 23 (38.3) | 14 (20.6) | 0.027 | |
 Diabetes mellitus | Pre-op | 11 (18.3) | 1 (1.5) | 0.001 |
Post-op | 5 (8.3) | 13 (19.1) | 0.125 | |
 Cerebrovascular event | Pre-op | 2 (3.3) | 0 (0) | 0.218 |
Post-op | 1 (1.7) | 0 (0) | 0.469 | |
 Coronary artery disease | Pre-op | 3 (5.0) | 3 (4.4) | 1.000 |
Post-op | 4 (6.7) | 5 (7.4) | 1.000 | |
 Heart failure | Pre-op | 1 (1.7) | 1 (1.5) | 1.000 |
Post-op | 1 (1.7) | 0 (0) | 0.469 | |
 Urinary tract infection | Post-op | 18 (30.0) | 24 (35.2) | 0.524 |
History of comorbidity n (%) | ||||
 Smoking | 13 (21.7) | 15 (22.1) | 0.957 | |
 Alcohol use | 1 (1.7) | 2 (2.9) | 1.000 | |
 Regular exercise habit | 7 (11.7) | 9 (13.2) | 1.000 | |
 Diabetes mellitus | 16 (26.7) | 14 (20.6) | 0.418 | |
 Insulin use | 15 (25.0) | 8 (11.8) | 0.066 | |
 Dyslipidemia | 30 (50.0) | 25 (36.8) | 0.131 | |
 Hypertension | 48 (80.0) | 50 (73.5) | 0.388 | |
 Coronary artery disease | 7 (11.7) | 7 (10.3) | 1.000 | |
 Myocardial infarction | 7 (4.7) | 6 (8.8) | 0.771 | |
 Coronary angiography | 11 (18.3) | 9 (13.2) | 0.472 | |
 Coronary angioplasty/stent | 6 (10.0) | 4 (5.9) | 0.514 | |
 Coronary bypass surgery | 2 (3.3) | 3 (4.4) | 1.000 | |
 Heart failure | 2 (3.3) | 1 (1.5) | 0.600 | |
 Heart valve disease | 1 (1.7) | 2 (2.9) | 1.000 | |
 Arrhythmia | 2 (3.3) | 3 (4.4) | 1.000 | |
 Peripheral artery disease | 2 (3.3) | 1 (1.5) | 0.600 | |
 Chronic lung disease | 5 (8.3) | 4 (5.9) | 0.733 | |
 Cerebrovascular event | 3 (5.0) | 0 (0) | 0.100 | |
 Hemorrhage | 1 (1.7) | - | ||
 Infarct | 2 (3.3) | - | ||
 Malignancy | 1 (1.7) | 0 (0) | 0.469 | |
 Hepatitis B virus n (%) | 3 (5.0) | 5 (7.4) | 0.722 | |
 Hepatitis C virus n (%) | 4 (6.7) | 2 (2.8) | 0.418 | |